Danica Pension Livsforsikringsaktieselskab raised its position in shares of Lumentum Holdings Inc. (NASDAQ:LITE – Free Report) by 72.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,287 shares of the technology company’s stock after purchasing an additional 1,378 shares during the quarter. Danica Pension Livsforsikringsaktieselskab’s holdings in Lumentum were worth $3,193,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the company. Red Spruce Capital LLC boosted its position in shares of Lumentum by 0.4% during the 3rd quarter. Red Spruce Capital LLC now owns 3,200 shares of the technology company’s stock valued at $3,108,000 after acquiring an additional 12 shares during the last quarter. CYBER HORNET ETFs LLC increased its position in Lumentum by 7.2% in the second quarter. CYBER HORNET ETFs LLC now owns 209 shares of the technology company’s stock worth $179,000 after purchasing an additional 14 shares during the last quarter. Hilltop National Bank increased its position in Lumentum by 26.8% in the second quarter. Hilltop National Bank now owns 71 shares of the technology company’s stock worth $61,000 after purchasing an additional 15 shares during the last quarter. TrinityBridge Ltd increased its position in Lumentum by 35.8% in the third quarter. TrinityBridge Ltd now owns 72 shares of the technology company’s stock worth $70,000 after purchasing an additional 19 shares during the last quarter. Finally, Signature Equity Partners LLC raised its stake in Lumentum by 220.0% during the third quarter. Signature Equity Partners LLC now owns 32 shares of the technology company’s stock valued at $31,000 after purchasing an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 94.05% of the company’s stock.
Insider Activity at Lumentum
In related news, CFO Wajid Ali sold 24,542 shares of the business’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $1,048.50, for a total transaction of $25,732,287.00. Following the completion of the transaction, the chief financial officer owned 75,074 shares in the company, valued at $78,715,089. The trade was a 24.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Yuen Wupen sold 307 shares of the company’s stock in a transaction on Tuesday, September 29th. The shares were sold at an average price of $945.00, for a total value of $290,115.00. Following the completion of the transaction, the insider directly owned 108,320 shares in the company, valued at $102,362,400. This trade represents a 0.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 94,496 shares of company stock worth $85,978,498. Company insiders own 0.28% of the company’s stock.
Key Headlines Impacting Lumentum
- Positive Sentiment: An analyst upgrade was followed by a reported 10.7% rise in LITE shares, while Sanford C. Bernstein also increased its price target—potential signs of improved analyst sentiment. Lumentum stock price up following analyst upgrade Sanford C. Bernstein increases price target
- Neutral Sentiment: Marvell, which has proposed acquiring Lumentum, added three independent directors to its board. The move adds governance context to the proposed deal, though the headline does not indicate a change in its terms. Another article frames Marvell as a key reference point for Lumentum’s valuation, but offers no specific deal update. Marvell adds independent directors Marvell and Lumentum valuation
- Negative Sentiment: Bearish signals include a UBS pessimistic forecast and a separate analyst downgrade that was associated with a decline in LITE shares. One report says the stock has fallen about 40% in a month, underscoring the pressure investors may want to see overcome before a recovery toward $1,000. UBS issues pessimistic forecast Lumentum shares fall on analyst downgrade Lumentum’s recent decline and recovery prospects
Analyst Ratings Changes
Several research firms have commented on LITE. UBS Group lowered their price objective on shares of Lumentum from $960.00 to $686.00 and set a “neutral” rating for the company in a research report on Tuesday, November 10th. Stonex Financial upgraded shares of Lumentum to a “strong-buy” rating in a report on Monday, October 26th. Sanford C. Bernstein upped their target price on shares of Lumentum from $635.00 to $700.00 and gave the company an “outperform” rating in a research report on Tuesday, November 10th. Rosenblatt Securities decreased their target price on shares of Lumentum from $1,300.00 to $900.00 and set a “buy” rating on the stock in a research report on Tuesday, November 3rd. Finally, Wolfe Research reaffirmed an “outperform” rating on shares of Lumentum in a report on Friday, August 21st. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $1,053.17.
Check Out Our Latest Stock Analysis on Lumentum
Lumentum Trading Down 4.5%
NASDAQ:LITE traded down $28.03 during mid-day trading on Friday, hitting $596.62. 3,646,860 shares of the stock traded hands, compared to its average volume of 6,441,538. The stock has a market capitalization of $54.11 billion, a price-to-earnings ratio of -7.58 and a beta of 1.64. Lumentum Holdings Inc. has a 52 week low of $215.35 and a 52 week high of $1,143.00. The firm’s 50 day moving average is $867.22 and its two-hundred day moving average is $808.06. The company has a quick ratio of 1.27, a current ratio of 1.61 and a debt-to-equity ratio of 0.01.
Lumentum (NASDAQ:LITE – Get Free Report) last announced its quarterly earnings data on Monday, November 2nd. The technology company reported $4.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.22 by $0.35. Lumentum had a negative net margin of 175.82% and a positive return on equity of 28.85%. The business had revenue of $1.26 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter last year, the firm earned $1.10 earnings per share. The firm’s quarterly revenue was up 136.5% compared to the same quarter last year. On average, equities research analysts predict that Lumentum Holdings Inc. will post 19.93 earnings per share for the current year.
About Lumentum
Lumentum Holdings Inc. develops and manufactures optical and photonic products used in communications networks and industrial applications. Its offerings include optical components, modules and lasers that help transmit and process data across telecommunications and data center networks. The company also supplies lasers and related technologies for industrial uses, including precision manufacturing and semiconductor production. Its products serve customers in markets around the world. Lumentum became an independent public company in 2015 through a spin-off from JDSU, now Viavi Solutions.
See Also
- Five stocks we like better than Lumentum
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
Want to see what other hedge funds are holding LITE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lumentum Holdings Inc. (NASDAQ:LITE – Free Report).
Receive News & Ratings for Lumentum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumentum and related companies with MarketBeat.com's FREE daily email newsletter.
